Who Decides? How ICER Impacts Patient Access→

The Institute for Clinical and Economic Review is a health economics organization that assesses the value of new drugs, medical devices and diagnostics. Though ICER is not a government entity, its decisions often impact medication coverage by public and private health plans. Nevertheless, patients, clinicians and caregivers lack meaningful opportunities to provide input on ICER’s value assessments.

Read One-Pager